joint venture BP Bunge Bioenergia S.A. up for sale, newspaper Valor Economico reported on August 9, 2022. The report, citing sources familiar with the matter, said Mubadala Investment Company PJSC and Raízen S.A. (BOVESPA:RAIZ4) were among those interested in buying the business. JPMorgan has been hired to advise BP Bunge on the deal, Valor said, adding that the company's assets were valued at between BRL 9 billion and BRL 10 billion ($1.96 billion).

BP and Raizen declined to comment, while Bunge, Mubadala and JPMorgan did not immediately respond to Reuters emailed requests for comment.